Jump to:
loading...| Preferred Name |
oritavancin |
| Synonyms |
LY 333328 |
| ID |
http://purl.bioontology.org/ontology/MESH/C100708 |
| altLabel |
LY 333328 Orbactiv (4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin LY333328 LY-333328 |
| cui |
C3852779 C1144403 C0391524 |
| Has mapping qualifier | |
| HM |
D000077427 D014640/Q000031 |
| Inverse of RB |
PUG62FRZ2E |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
20140808 |
| MeSH Frequency |
241 |
| MMR |
20220722 |
| notation |
C100708 |
| PA |
D000900 |
| PI |
*ANTI-BACTERIAL AGENTS (1996-2005) *GLYCOPEPTIDES (2006-2018) |
| prefLabel |
oritavancin |
| SC |
1 |
| SRC |
J Antibiot (Tokyo) 1996 Jun;49(6):575-81 |
| TERMUI |
T294246 T001122662 T000864039 T591675 T518799 T294247 |
| TH |
FDA SRS (2014) NLM (2004) FDA SRS (2017) NLM (2002) NLM (1996) NLM (2014) INN (19XX) |
| tui |
T109 T116 T195 |
Create New Mapping